Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 7: 42689, 2017 03 10.
Article in English | MEDLINE | ID: mdl-28281639

ABSTRACT

The community structure of colonised bacteria in the gastrointestinal tracts (GITs) of pre-weaned calves is affected by extrinsic factors, such as the genetics and diet of the calves; however, the dietary impact is not fully understood and warrants further research. Our study revealed that a total of 6, 5, 2 and 10 bacterial genera showed biologically significant differences in the GITs of pre-weaned calves fed four waste-milk diets: acidified waste milk, pasteurised waste milk, untreated bulk milk, and untreated waste milk, respectively. Specifically, generic biomarkers were observed in the rumen (e.g., Bifidobacterium, Parabacteroides, Fibrobacter, Clostridium, etc.), caecum (e.g., Faecalibacterium, Oxalobacter, Odoribacter, etc.) and colon (e.g., Megamonas, Comamonas, Stenotrophomonas, etc.) but not in the faeces. In addition, the predicted metabolic pathways showed that the expression of genes related to metabolic diseases was increased in the calves fed untreated waste milk, which indicated that untreated waste milk is not a suitable liquid diet for pre-weaned calves. This is the first study to demonstrate how different types of waste milk fed to pre-weaned calves affect the community structure of colonised bacteria, and the results may provide insights for the intentional adjustment of diets and gastrointestinal bacterial communities.


Subject(s)
Gastrointestinal Microbiome , Milk , Waste Products , Weaning , Animal Feed , Animals , Bacteria/classification , Biodiversity , Cattle , Gastrointestinal Tract/metabolism , Gastrointestinal Tract/microbiology , Metabolic Networks and Pathways
2.
J Anim Physiol Anim Nutr (Berl) ; 101(5): 964-973, 2017 Oct.
Article in English | MEDLINE | ID: mdl-27272969

ABSTRACT

Eighty Dorper × thin-tailed Han cross-bred non-castrated male lambs [mean body weight (BW), 25.87 ± 1.06 kg] were randomly allocated to one of five different concentrations of slow-release urea (urea phosphate, UP). The feed consisted of an equal amount of concentrate diet and roughage; the concentrate feed was formulated to be isoenergetic and isonitrogenic and contained 0%, 1%, 2%, 4% and 8% UP (UP0.0, UP1.0, UP2.0, UP4.0 and UP8.0, respectively) as a replacement for soya bean meal. Feed intake, BW, average daily gain (ADG), feed utilisation efficiency (FUE), absolute and relative organ weights and biochemical and histopathological parameters were measured. Feed intake, BW, ADG and FUE significantly decreased in the group receiving UP8.0 (p < 0.05), but no difference was found among the other groups (p > 0.05). Quadratic equations were developed between the UP dosage in the concentrate feed and ADG or FUE (r2  = 0.973 for ADG and r2  = 0.761 for FUE) to determine the appropriate dosage of UP given the desire to maximise either ADG or FUE, the appropriate dosage (feed concentration) was calculated as 2.01% UP to achieve the greatest ADG or 2.13% UP to achieve the best FUE. The relative weight of the liver (% BW) in the UP2.0 groups was significantly greater than that of UP0.0 (p < 0.05), and the relative weight of the intestine in the UP8.0 was significantly greater than that of UP0.0 (p < 0.05); the relative weight of the carcass, heart, spleen, lung, kidney, rumen, reticulum, omasum and abomasum did not differ among treatments (p > 0.05). The UP8.0 treatment significantly increased serum phosphorus levels (p < 0.05) and decreased the levels of alkaline phosphatase, glucose and calcium (Ca) compared with the lower UP dosage (p < 0.05). No histopathological differences were found in either hepatic tissues or renal tissues among treatments. Dietary UP as a replacement for soya bean in concentrate feeds for mutton sheep should not exceed 4%, as higher dosing may cause malnutrition and mineral disorders.


Subject(s)
Animal Feed/analysis , Diet/veterinary , Sheep/growth & development , Urea/pharmacology , Animal Nutritional Physiological Phenomena , Animals , Delayed-Action Preparations , Dietary Supplements , Male , Sheep/blood , Urea/administration & dosage
3.
J Anim Physiol Anim Nutr (Berl) ; 100(6): 1081-1089, 2016 Dec.
Article in English | MEDLINE | ID: mdl-27079689

ABSTRACT

The net and metabolizable energy (NE and ME) requirements of Dorper cross-bred female lambs with BWs of 20-35 kg were assessed in a comparative slaughter trial. Thirty-five Dorper × thin-tailed Han cross-bred female lambs weaned at ~50 days of age (20.3 ± 2.15 kg BW) were used. Seven randomly selected lambs were slaughtered at the start of the trial (baseline group). An intermediate group consisting of seven randomly selected lambs fed ad libitum was slaughtered when the lambs reached an average BW of 28.5 kg. The remaining 21 lambs were allotted randomly to three levels of dry matter intake: ad libitum or restricted to 70% or 40% of the ad libitum intake. All the lambs were slaughtered when the sheep fed ad libitum reached a BW of 35 kg. Total body energy, nitrogen, fat, ash and moisture content were determined. In a digestibility trial, an additional 15 Dorper × thin-tailed Han cross-bred female lambs (28.7 ± 1.75 kg BW) were housed in metabolism cages and used in a completely randomized design experiment to evaluate the ME value of the diet at the three feed intake levels. The maintenance requirements for NE and ME were 245.5 and 380.3 kJ/kg metabolic shrunk body weight (SBW0.75 ) respectively. The partial efficiency of energy use for maintenance was 0.645. The NE requirements for growth ranged from 1.18 to 5.18 MJ/d for the lambs gaining 100-350 g/d from 20 to 35 kg BW. Partial efficiency of ME for growth was 0.44. In conclusion, the current study suggests that the NE requirement for maintenance and growth of Dorper early-weaned cross-bred female lambs is lower than the current AFRC and NRC recommendations.


Subject(s)
Animal Feed/analysis , Diet/veterinary , Energy Metabolism/physiology , Sheep/physiology , Animal Nutritional Physiological Phenomena , Animals , Energy Intake , Female , Sheep/genetics , Weaning , Weight Gain
4.
Nutr Cancer ; 37(1): 65-72, 2000.
Article in English | MEDLINE | ID: mdl-10965521

ABSTRACT

This study was designed to determine the effects of dietary n-3/n-6 fatty acid ratios on preneoplastic foci and the microsomal monooxygenase system in rat hepatocarcinogenesis. Male Sprague-Dawley rats were fed four kinds of diets containing 15% (wt/wt) fat with different n-6/n-3 ratios: low ratio (> or = 1.0) with tuna oil, low ratio (> or = 1.0) with perilla oil, moderate ratio (< or = 4.0), and high ratio (< or = 10.0). Hepatocarcinogenesis was induced by diethylnitrosamine and partial hepatectomy. The moderate ratio diet decreased significantly the area and number of placental glutathione S-transferase-positive foci compared with the high ratio diet and low ratio diet with perilla oil. The fatty acid composition of microsomal membrane varied extensively, reflecting the dietary n-6/n-3 ratios. Liver microsomal lipid peroxidation was significantly decreased in the group fed the low ratio diet with tuna oil compared with the moderate and high ratio groups. Glucose-6-phosphatase activity, which reflects membrane stability, was significantly higher in the low ratio groups than in the high ratio group. The monooxygenase activities were increased significantly in the moderate ratio group compared with the high ratio group. These results suggest that a moderate n-6/n-3 ratio (< or = 4.0) may be the most effective in decreasing preneoplastic foci by elevating the monooxygenase activities and n-3 fatty acids in fish oil may have a protective effect by lowering the lipid peroxidation and stabilizing the microsomal membrane during rat hepatocarcinogenesis.


Subject(s)
Cytochrome P-450 Enzyme System/metabolism , Fatty Acids, Omega-3/administration & dosage , Fatty Acids, Unsaturated/administration & dosage , Liver Neoplasms/prevention & control , Microsomes, Liver/enzymology , Animals , Dietary Fats, Unsaturated/administration & dosage , Dietary Fats, Unsaturated/pharmacology , Fatty Acids, Omega-3/metabolism , Fatty Acids, Omega-6 , Fatty Acids, Unsaturated/metabolism , Glucose-6-Phosphatase/metabolism , Glutathione Transferase/metabolism , Lipid Peroxidation , Liver Neoplasms/etiology , Male , Microsomes, Liver/metabolism , Models, Animal , Rats , Rats, Sprague-Dawley , Thiobarbituric Acid Reactive Substances/analysis
5.
Korean J Intern Med ; 11(1): 58-68, 1996 Jan.
Article in English | MEDLINE | ID: mdl-8882477

ABSTRACT

To evaluate the clinical efficacy of alpha-interferon(IFN-alpha) plus cis-platinum in hepatocellular carcinoma(HCC). 56 inoperable patients with HCC were divided into IFN-alpha plus cis-platinum treated group (n = 30) and no antitumor therapy group (n = 26). The survival of IFN-alpha plus cis-platinum treated patients was significantly better than that of patients who received no antitumor therapy (p = 0.001). Median survival time was 33 weeks and 14.0 weeks, respectively. The cumulative estimated survival rates of our IFN-alpha plus cis-platinum treated group (93.5% at 3mo, 75.0% at 6mo) were for longer than that of the no antitumor therapy group (84.6% at 3mo, 57.7% at 6mo). Objective tumor regression, greater than 50% was observed in 13.3% (4 of 30) of patients receiving IFN-alpha plus cis-platinum. By the univariate analysis, the absence of portal vein thrombus (p < 0.05), alkaline phosphatase lesser than 280 U/L (p = 0.001), total bilirubin less than 2.0 mg% (p < 0.05), serum triglyceride less than 155 mg/dl (p < 0.05) were shown to be the factors most significantly favoring a better survival. By the multivariate analysis, using Cox proportional hazards model, IFN-alpha plus cis-platinum treated group (p = 0.0001), alkaline phosphatase less than 280 mg/dl (p = 0.005), the absence of portal vein thrombus (p = 0.020) were independent favorable prognostic factors. We conclude that IFN-alpha plus cis-platinum is useful in patients with inoperable HCC and the above favorable prognostic factors may also be useful in the design and analysis of future clinical trials of systemic chemotherapy for HCC.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carcinoma, Hepatocellular/drug therapy , Liver Neoplasms/drug therapy , Adult , Aged , Antineoplastic Agents/administration & dosage , Antineoplastic Agents/therapeutic use , Antineoplastic Combined Chemotherapy Protocols/administration & dosage , Carcinoma, Hepatocellular/diagnosis , Carcinoma, Hepatocellular/physiopathology , Cisplatin/administration & dosage , Cisplatin/therapeutic use , Female , Humans , Interferon-alpha/administration & dosage , Interferon-alpha/therapeutic use , Liver Neoplasms/diagnosis , Liver Neoplasms/physiopathology , Male , Middle Aged
SELECTION OF CITATIONS
SEARCH DETAIL
...